Web Analytics

3 Latest Announced Rounds

  • $55,000,000
    Seed

    2 Investors

    Financial Services
    Dec 18th, 2024
  • $5,400,000
    Seed
    Robotics Engineering
    Dec 18th, 2024
  • $11,500,000
    Series A

    6 Investors

    Embedded Software Products
    Dec 18th, 2024
$874.90M Raised in 43 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Alessa Therapeutics, Inc.

start up
United States - San Carlos, California
  • 13/12/2024
  • Seed
  • $15,000,000

Alessa Therapeutics is developing localized treatments for solid organ disease.


Related People

Pamela N MunsterFounder

Pamela N Munster United States - San Francisco, California

A native of Switzerland, I am a professor of medicine at the University of California San Francisco, where I am leader of the Experimental Therapeutics Program/Helen Diller Family Comprehensive Cancer Center, Director of The Early Phase Clinical Trials Unit, and coleader of the Center for BRCA Research. In addition to my clinical research, my laboratory based research, is focused on epigenetics and developing novel strategies to treat patients with incurable cancers. I have founded AlessaTherapeutics focused on the sustained localized delivery of anti-cancer agents and i have many years of experience in bringing novel cancer therapeutics into the clinic. I serve on multiple local, national, and international committees focused on developing new treatments for cancer and serve on the board of directors for private companies. As part as my academic focus i have authored textbooks and am a frequent lecturer. I am passionate about breast awareness with campaigns in the US, UAE, and India and have recently authored a book describing the challenges on living with cancer in Twisting Fate.